Lazard Asset Management’s Ortho Clinical Diagnostics Holdings plc Ordinary Shares OCDX Stock Holding History

Lazard Asset Management’s Portfolio OCDX Stock Details OCDX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-3,325,462	Closed	-$62.1M	–	2648
2022 Q1	$62.1M	Sell	3,325,462 -433,127	-12%	-$7.79M	0.07%	236
2021 Q4	$80.4M	Buy	3,758,589 +319,108	+9%	+$6.29M	0.09%	210
2021 Q3	$63.6M	Buy	3,439,481 +892,645	+35%	+$18M	0.07%	235
2021 Q2	$54.5M	Buy	2,546,836 +494,406	+24%	+$10.1M	0.06%	258
2021 Q1	$39.6M	Buy	+2,052,430	New	+$36.2M	0.05%	303

Other funds holding OCDX

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Lazard Asset Management's OCDX Position: Q2 2022 in Review

Lazard Asset Management sold out of Ortho Clinical Diagnostics Holdings plc Ordinary Shares (OCDX) in Q2 2022, closing a stake of 3,325,462 shares — an estimated $62.1M sold.

Lazard Asset Management first reported a position in OCDX in Q1 2021 and held it in 5 quarters. The position peaked at $80.4M in Q4 2021. 1 fund tracked by Wall St. Rank holds OCDX as of Q2 2022.

Lazard Asset Management reported no remaining Ortho Clinical Diagnostics Holdings plc Ordinary Shares position as of Q2 2022 after selling out during the quarter.
Lazard Asset Management sold 3,325,462 Ortho Clinical Diagnostics Holdings plc Ordinary Shares shares in Q2 2022, an estimated $62.1M.
Lazard Asset Management first reported a position in Ortho Clinical Diagnostics Holdings plc Ordinary Shares in Q1 2021 and held it in 5 quarters.
Lazard Asset Management's Ortho Clinical Diagnostics Holdings plc Ordinary Shares position peaked at $80.4M in Q4 2021.
1 fund tracked by Wall St. Rank held Ortho Clinical Diagnostics Holdings plc Ordinary Shares as of Q2 2022.

Based on Lazard Asset Management's 13F filing for Q2 2022, filed 9 Aug 2022.